Chinese Researchers Discover Why Regulatory T Cells Fail in Rheumatoid Arthritis: Iron Overload Triggers Cell Death

A groundbreaking discovery by Shanghai Jiao Tong University researchers, published in Advanced Science, reveals why regulatory T cells in rheumatoid arthritis joints fail to suppress inflammation - and points to ferroptosis, a newly recognized form of cell death, as the key culprit.

Joint affected by rheumatoid arthritis

The Discovery: Iron-Driven Cell Death
The Treg Paradox in RA
Ferroptosis Mechanism Revealed
Why Some Cells Resist Death
Clinical Implications
Sources

The Discovery: Iron-Driven Cell Death {#discovery}

Microscope for cell research

On May 19, 2026, researchers from Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine published a landmark study in Advanced Science (IF≈15), revealing that synovial iron overload in rheumatoid arthritis (RA) creates a microenvironment that triggers ferroptosis - a form of regulated cell death driven by iron-dependent lipid peroxidation.

The study, led by Chen Jingrong and colleagues from the Division of Rheumatology and Department of Immunology, discovered that exposure to RA synovial fluid induces ferroptosis in regulatory T cells (Tregs), causing lipid peroxide-driven mitochondrial dysfunction characterized by electron transport chain (ETC) collapse.

This finding explains a long-standing paradox in rheumatoid arthritis: Tregs are numerically enriched in the synovium yet functionally impaired, leading to a loss of immune tolerance and persistent inflammation.

The Treg Paradox in RA {#paradox}

Medical laboratory

Regulatory T cells are crucial guardians of immune tolerance, normally suppressing excessive immune responses. In rheumatoid arthritis, however, despite increased numbers of Tregs in the inflamed joints, these cells fail to control inflammation effectively.

According to a bibliometric analysis published in Autoimmunity in 2026 by Li Ruohui and colleagues from the Chinese Academy of Medical Sciences, ferroptosis has emerged as a major research hotspot in autoimmune diseases since 2018, with GPX4 identified as a central molecule in the ferroptosis pathway.

The Shanghai Jiao Tong University research provides the mechanistic explanation: the iron-rich environment of RA joints drives Tregs into ferroptosis, destroying their ability to maintain immune balance. This process involves TXK-STAT3/PLCγ1 activation that further disrupts Treg homeostasis.

Ferroptosis Mechanism Revealed {#mechanism}

Doctor consulting with patient

Ferroptosis differs fundamentally from other forms of cell death like apoptosis. It is characterized by iron-dependent accumulation of lipid peroxides and can be triggered when cells lose the ability to detoxify these harmful molecules.

The researchers found that RA synovial fluid contains elevated iron levels that overwhelm Treg defenses. The iron catalyzes the formation of lipid peroxides through Fenton reactions, leading to oxidative damage to mitochondrial membranes and collapse of the electron transport chain.

Key to this process is the downregulation of GPX4 (glutathione peroxidase 4), the primary enzyme that protects cells from ferroptosis by converting toxic lipid peroxides to harmless alcohols. When GPX4 activity is compromised, Tregs become vulnerable to iron-driven death.

The study also identified that ferroptotic Tregs undergo metabolic shifts that further impair their suppressive function, creating a vicious cycle where dying Tregs cannot control the inflammatory cells that perpetuate the iron-rich microenvironment.

Why Some Cells Resist Death {#resistance}

Medical consultation

While Tregs succumb to ferroptosis in RA joints, other cells - particularly fibroblast-like synoviocytes (FLS) - survive and even thrive in the same iron-rich environment. A complementary study published in Arthritis Research & Therapy in May 2026 by Liu Jiaxi and colleagues from Peking University First Hospital explains this resistance.

RA-FLS cells activate the IRE1/p-JNK/NRF2 axis, which upregulates GPX4 and other antioxidant defenses, allowing them to resist ferroptosis while continuing to promote inflammation. This differential vulnerability creates a battlefield where inflammatory cells survive while immune-regulating cells die.

The Beijing team’s research included 17 patients (9 with RA, 8 with osteoarthritis as controls) undergoing joint replacement surgery, providing direct evidence of ferroptosis resistance mechanisms in human synovial tissue.

Clinical Implications {#implications}

Medical research equipment

The discovery of ferroptosis as a mechanism of Treg failure in RA opens new therapeutic possibilities. Current RA treatments primarily target inflammatory pathways but do not address the fundamental loss of immune regulation.

Targeting ferroptosis could restore Treg function by either reducing iron overload in joints or boosting GPX4 activity specifically in Tregs. Iron chelation therapy, already used in other iron overload conditions, might find new application in rheumatoid arthritis.

The research was supported by multiple grants from the National Natural Science Foundation of China, including Youth Program grants (82201998, 82201999) and General Program grants (82371817, 82572054), highlighting China’s commitment to understanding autoimmune disease mechanisms.

For the estimated 18 million people worldwide living with rheumatoid arthritis, this research offers new hope. By addressing the root cause of Treg dysfunction rather than just suppressing symptoms, future therapies might achieve more durable remission and prevent joint damage.

Sources {#sources}

← Back to News